Burden of Proof Research Reference

PDF: Granny Storm Crow’s MMJ Reference List

Well, here I am again, staring at this blank screen, trying to figure out what to say so you will share the information I have gathered. ―Once the medical facts about cannabis become known, the need for legalization decriminalization becomes obvious! How many times have I said that? I need YOU to educate those around you. I can‘t do it alone!

INDEX

Introduction……………………………………………………………………………………………………1

ACEA/ ARACHIDONYL-2′-CHLOROETHYLAMIDE……………………………………….. 2

ACHILLES TENDINOSIS……………………………………………………………………….4

ACNE………………………………………………………………………………………………4

ADD/ ADHD…………………………………………………………………………………………………..4

ADDICTION…………………………………………………………………………………………………..6

2-AG /2-ARACHIDONOYLGLYCEROL……………………………………………………….8

2-AGE/ 2-ARACHIDONYL GLYCERYL ETHER/ NOLADIN ETHER……………….17

AGING/ USE BY SENIORS ……………………………………………………………………………………18

AIDS – see HIV

AJULEMIC ACID………………………………………………………………………………………….21

ALCOHOLISM………………………………………………………………………………………………22

ALLERGIES AND CANNABIS………………………………………………………………………26

ALLERGIES TO CANNABIS…………………………………………………………………..27

ALS / AMYOTROPHIC LATERAL SCLEROSIS…………………………………………….28

ALZHEIMER’S DISEASE………………………………………………………………………………30

AM- 251…………………………………………………………………………………………………………36

AM-281…………………………………………………………………………………………..40

AM-404…………………………………………………………………………………………………….41

AM-630…………………………………………………………………………………………………….42

AM-694…………………………………………………………………………………………..43

AM-1241………………………………………………………………………………………………………..43

AM-1346………………………………………………………………………………………………………..44

AM-1710…………………………………………………………………………………………45

AM-2233………………………………………………………………………………………….45

AM- 4054………………………………………………………………………………………………………45

AM- 4113………………………………………………………………………………………………………46

AM 6545………………………………………………………………………………………….46

AMOTIVATIONAL SYNDROME………………………………………………………………….46

ANANDAMIDE……………………………………………………………………………………………47

ANECDOTAL / PERSONAL STORIES…………………………………………………………..65

ANOREXIA NERVOSA – also see APPETITE STIMULANT ………………………..66

ANTI-BACTERIAL PROPERTIES…………………………………………………………………68

ANTI-FUNGAL PROPERTIES………………………………………………………………………69

ANTI-INFLAMMATORY PROPERTIES………………………………………………………..69

ANTIMICROBIAL PROPERTIES………………………………………………………………76

ANTIOXIDANT PROPERTIES……………………………………………………………………….77

ANXIOLYTIC EFFECTS…………………………………………………………………………………78

APPETITE STIMULANT………………………………………………………………………………..82

ARACHIDONYL-2′-CHLOROETHYLAMIDE- see ACEA

2-ARACHIDONOYLGLYCEROL – see 2-AG

ARTHRITIS…………………………………………………………………………………………………….90

AS- 1535907……………………………………………………………………………………..93

AS-1907417………………………………………………………………………………………94

673ASTHMA…………………………………………………………………………………………………..94

ATHEROSCLEROSIS……………………………………………………………………………………….95

AUTISM………………………………………………………………………………………………………….97

BACK PAIN……………………………………………………………………………………………………..99

BETA-CARYOPHYLENE/ (E)-BCP……………………………………………………………………99

BIPOLAR DISORDER…………………………………………………………………………………………………100

BLADDER/ URINARY FUNCTIONS……………………………………………………………………………100

BLEPHAROSPASM…………………………………………………………………………………………………….100

BLOOD……………………………………………………………………………………………………………………….100

BLOOD PRESSURE…………………………………………………………………………………………………….103

BONES- see OSTEOPOROSIS

BONE MARROW……………………………………………………………………………………………………106

BOWEL DISORDERS – also see GERD, COLITIS …………………………………………………..106

BRAIN CELLS- see NEURONS

BRAIN- PHYSICAL EFFECTS…………………………………………………………………………………….115

BRAIN TRAUMA………………………………………………………………………………………………………..117

BREASTFEEDING/ INFANT APPETITE…………………………………………………………………….119

BULIMIA…………………………………………………………………………………….120

CANCER – BASAL CELL CARCINOMA – see CANCER – SKIN

CANCER – BLADDER / URETHRAL………………………………………………………..121

CANCER- BONE…………………………………………………………………………………………………………121

CANCER- BREAST……………………………………………………………………………………………………..122

CANCER- CERVICAL…………………………………………………………………………………………………125

CANCER- CHEMOTHERAPY- see CHEMOTHERAPY

CANCER- CHOLANGIOCARCINOMA………………………………………………………………………..126

CANCER- COLON /COLORECTAL……………………………………………………………………………..127

CANCER – ENDOMETRIAL………………………………………………………………….129

CANCER- GASTRIC……………………………………………………………………………………………………129

CANCER- GLIOMA……………………………………………………………………………………………………130

CANCER- HEAD AND NECK……………………………………………………………………………………..135

CANCER- KAPOSI’S SARCOMA………………………………………………………………………………..135

CANCER – KIDNEY………………………………………………………………………….136

CANCER- LEUKEMIA……………………………………………………………………………………………….136

CANCER – LIVER…………………………………………………………………………….137

CANCER- LUNG………………………………………………………………………………………………………..138

CANCER- LYMPHOMA……………………………………………………………………………………………..141

CANCER- MELANOMA……………………………………………………………………………………………..142

CANCER – NEUROBLASTOMA………………………………………………………………………………….143

CANCER- ORAL…………………………………………………………………………………………………………144

CANCER- OVARIAN…………………………………………………………………………………………………..145

674CANCER- PANCREATIC……………………………………………………………………………………….145

CANCER- PITUITARY ADENOMA…………………………………………………………………………….146

CANCER – PNET / PRIMITIVE NEUROECTODERMAL TUMOR………………………..146

CANCER- PROSTATE…………………………………………………………………………………………………146

CANCER – RHABDOMYOSARCOMA…………………………………………………………………………148

CANCER- RISK CANNABIS VS TOBACCO………………………………………………………………..149

CANCER- SKIN…………………………………………………………………………………………………………..149

CANCER – SQUAMOUS CELL CARCINOMA………………………………………………150

CANCER- TESTICULAR……………………………………………………………………………………………..151

CANCER – THYMOMA……………………………………………………………………………………………….151

CANCER- THYROID…………………………………………………………………………………………………..151

CANCER- VARIOUS/ UNNAMED……………………………………………………………………………….152

CANNABICHROMENE……………………………………………………………………………………………….159

CANNABIDIOL/ CBD…………………………………………………………………………………………………160

CANNABIDIOLIC ACID………………………………………………………………………182

CANNABIGEROL / CBG……………………………………………………………………………………………..182

CANNABINOID HYPEREMESIS SYNDROME…………………………………………….184

CANNABINOID RECEPTORS – see ENDOCANNABINOID SYSTEM, CBRs

CANNABINOR…………………………………………………………………………………186

CANNADOR……………………………………………………………………………………………………………….186

CARDIOVASCULAR- see HEART DISEASE

CARPAL TUNNEL SYNDROME…………………………………………………………….187

CBR- CB 1 RECEPTORS-…………………………………………………………………………………………….187

CBR – CB 2 RECEPTORS………………………………………………………………………………………..205

CBR– GPR 40 RECEPTORS…………………………………………………………………….218

CBR – GPR 55/ CB 3 RECEPTORS……………………………………………………………………………….219

CBR – GPR109 RECEPTORS………………………………………………………………………………………..221

CBR – GPR 119 RECEPTORS………………………………………………………………………………………222

CELIAC DISEASE……………………………………………………………………………..222

CEREBRAL PALSY……………………………………………………………………………223

CESAMET- see NABILONE

CHEMICAL COMPOSITION……………………………………………………………………………………….223

CHEMOTHERAPY………………………………………………………………………………………………………231

CHILDREN/ YOUNG ADULTS……………………………………………………………………………………236

CHOLERA………………………………………………………………………………………243

CHOLESTEROL……………………………………………………………………………….244

CHRONIC FATIGUE SYNDRONE……………………………………………………………244

COGNATIVE EFFECTS- see IQ

COLITUS……………………………………………………………………………………….244

COPD/ LUNG FUNCTION…………………………………………………………………………………………..246

COUGH………………………………………………………………………………………………………………………247

COWPOX………………………………………………………………………………………248

CP- 47,497…………………………………………………………………………………………………………………..248

CP 50,556-1 / LEVONANTRADOL…………………………………………………………..250

CP- 55,940…………………………………………………………………………………………………………………..251

CROHN’S – see BOWEL DISORDERS

675CRUETZFELDT-JACOB DISEASE- see MAD COW DISEASE

CT-3 – also see AJULMIC ACID… …………………………………………………………………………….254

CYSTIC FIBROSIS………………………………………………………………………………………………………254

CYSTITIS……………………………………………………………………………………………………………………255

DENTISTRY – see TEETH

DEPRESSION……………………………………………………………………………………………………………..255

DERMATITIS……………………………………………………………………………………………………………..259

DEXANABINOL – see HU-211

DIABETES………………………………………………………………………………………………………………….261

DOWN‘S SYNDROME………………………………………………………………………..267

DRIVING AND CANNABIS…………………………………………………………………………………………267

DRONABINOL……………………………………………………………………………………………………………270

DRUG INTERACTIONS- see INTERACTIONS WITH OTHER DRUGS

DRUG TESTING…………………………………………………………………………………………………………274

DRUG TESTING – BLOOD………………………………………………………………………………………….277

DRUG TESTING – BREATH TEST…………………………………………………………..279

DRUG TESTING – HAIR……………………………………………………………………………………………..279

DRUG TESTING- OTHER……………………………………………………………………………………………281

DRUG TESTING – ORAL…………………………………………………………………………………………….282

DRUG TESTING – URINE……………………………………………………………………………………………283

DYSKINESIA…………………………………………………………………………………..288

DYSTONIA…………………………………………………………………………………………………………………289

ECZEMA……………………………………………………………………………………………………………………290

EDEMA…………………………………………………………………………………………………………… ……..291

EHLERS-DANLOS SYNDROME………………………………………………………………………………..291

ELMIRIC ACIDS………………………………………………………………………………………………………..291

ENCEPHALITUS………………………………………………………………………………………………………..292

ENCEPHALOMYELITIS/ EAE……………………………………………………………………………………292

ENDOCANNABINOIDS……………………………………………………………………………………………..293

ENDOCANNABINOID SYSTEM – also see CBRs ……………………………………………………..301

ENDOMETRIOSIS……………………………………………………………………………………………………..319

EPILEPSY…………………………………………………………………………………………………………………..319

FAMILIAL MEDITERRANEAN FEVER……………………………………………………………………..325

FERTILITY………………………………………………………………………………………………………………..325

FEVER/ TEMPERATURE CONTROL………………………………………………………………………….327

FIBROMYALGIA……………………………………………………………………………………………………….329

FLU / INFLUENZA……………………………………………………………………………………………………..331

676GATEWAY THEORY…………………………………………………………………………………………….331

GENDER-BASED DIFFERENCES……………………………………………………………………………….333

GERD/GASTRO-ESOPHAGEAL REFLUX DISEASE……………………………………………………336

GLAUCOMA………………………………………………………………………………………………………………336

GOUT…………………………………………………………………………………………..341

GRANULOMA…………………………………………………………………………………341

GRAVE’S DISEASE…………………………………………………………………………………………………….341

GWP- 42006…………………………………………………………………………………….342

GYNOCOLOGY AND OBSTETRICS…………………………………………………………………………..342

HAIR…………………………………………………………………………………………………………………………..343

HEADACHE – see MIGRAINE

HEARING also see TINNITUS ………………………………………………………………………………….344

HEART DISEASE/ CARDIOVASCULAR…………………………………………………………………….344

HEMORRHAGIC SHOCK……………………………………………………………………..353

HEPATITIS…………………………………………………………………………………………………………………353

HEREDITARY MULTIPLE EXTOSES……………………………………………………….355

HERPES VIRUS…………………………………………………………………………………………………………..355

HEXAHYDROCANNABINOLS……………………………………………………………………………………356

HICCUPS…………………………………………………………………………………………………………………….356

HISTORICAL STUDIES -PRE 1937………………………………………………………………………………357

HISTORY- ANCIENT USE…………………………………………………………………………………………..360

HISTORY-1937 TO PRESENT……………………………………………………………………………………..361

HIV / AIDS………………………………………………………………………………………………………………….365

HORMONES……………………………………………………………………………………………………………….369

HPV/ HUMAN PAPILLOMA VIRUS……………………………………………………………………………373

HU-210……………………………………………………………………………………………………………………….373

HU-211……………………………………………………………………………………………………………………….377

HU-308……………………………………………………………………………………………………………………….378

HU-310…………………………………………………………………………………………379

HU-320……………………………………………………………………………………………………………………….379

HU-331……………………………………………………………………………………………………………………….379

HU-910…………………………………………………………………………………………380

HUNTINGTON’S DISEASE…………………………………………………………………………………………380

HYPEREMESIS – see CANNABINOID HYPEREMESIS SYNDROME

HYSTERECTOMY………………………………………………………………………………………………………383

IBS – see BOWEL DISORDERS

IDIOPATHIC INTRACRANIAL HYPERTENSION……………………………………………………….384

IDRASIL………………………………………………………………………………………..384

677IMMUNE SYSTEM……………………………………………………………………………………………….384

INCONTINENCE – see BLADDER OVERACTIVITY

INDICATIONS AND CLINICAL USES…………………………………………………………………………387

INFLUENZA- see FLU

INJURIES – see WOUNDS/ INJURIES

INTERACTIONS WITH OTHER DRUGS……………………………………………………………………..388

31 – IP 751 see AJULEMIC ACID

ISSAC‘S SYNDROME/ ACQUIRED NEUROMYOTONIA…………………………………397

IQ/ MEMORY/ COGNATIVE EFFECTS……………………………………………………………………….397

JWH-015……………………………………………………………………………………………………………………..403

JWH-018……………………………………………………………………………………………………………………..405

JWH-073……………………………………………………………………………………………………………………..408

JWH-100 / AM -678……………………………………………………………………………409

JWH-133……………………………………………………………………………………………………………………..409

KIDNEYS……………………………………………………………………………………………………………………412

KNOCK-OUT MICE………………………………… ………………………………………413

LEGIONAIRES DISEASE……………………………………………………………………..415

LEISHMANIASIS………………………………………………………………………………………………………..416

LIVER – NON HEPATITIS……………………………………………………………………………………………416

LONG TERM USE EFFECTS……………………………………………………………………………………….421

LUNG FUNCTION………………………………………………………………………………………………………423

LUPUS………………………………………………………………………………………………………………………..424

LYME DISEASE……………………………………………………………………………….425

MACULAR DEGENERATION………………………………………………………………..425

MAD COW/ CRUETZFELDT-JACOB DISEASE…………………………………………………………..425

MARINOL………………………………………………………………………………………………………………….426

MDA 19…………………………………………………………………………………………427

MEIGE’S SYNDROME………………………………………………………………………………………………..428

MEMORY- see IQ

MENIERE’S SYNDROME……………………………………………………………………………………………428

MENINGITIS………………………………………………………………………………………………………………428

MENOPAUSE……………………………………………………………………………………………………………..428

MENTAL DISORDERS – see SCHIZOPHRENIA

METHODS OF USE – BREATH STRIPS……………………………………………………429

METHODS OF USE- CAPSULES………………………………………………………………………………..430

METHODS OF USE – DECARBOXYLATION………………………………………………430

678METHODS OF USE- E-CIGARETTES……………………………………………………..430

METHODS OF USE- EDIBLES…………………………………………………………………………………..431

METHODS OF USE- EDIBLES – BEVERAGES…………………………………………………………..432

METHODS OF USE- EDIBLES – FOODS…………………………………………………………………..433

METHODS OF USE – INHALERS…………………………………………………………..434

METHODS OF USE – INJECTION………………………………………………………………………………..435

METHODS OF USE – NASAL SPRAYS………………………………………………………………………..436

METHODS OF USE – RSO / RICK SIMPSON‘S OIL………………………………………..436

METHODS OF USE – SMOKING…………………………………………………………………………………437

METHODS OF USE – SUPPOSITORIES……………………………………………………………………….441

METHODS OF USE – TINCTURES………………………………………………………………………………441

METHODS OF USE – TOPICAL OINTMENTS……………………………………………………………..442

METHODS OF USE -TRANSDERMAL PATCH……………………………………………………………444

METHODS OF USE – VAPORIZERS……………………………………………………………………………444

METHODS OF USE- VARIOUS…………………………………………………………………………………..446

MIGRAINE/ HEADACHE……………………………………………………………………………………………447

MISCELANEOUS STUFF…………………………………………………………………………………………….448

MORNING SICKNESS………………………………………………………………………………………………..454

MORTALITY RATES………………………………………………………………………………………………….455

MOTION SICKNESS……………………………………………………………………………………………………456

MRSA/ METHICILLIN-RESISTANT STAPHLOCOCCUS AUREUS……………………………..457

MULTIPLE SCLEROSIS/ MS……………………………………………………………………………………….458

MUSCULAR DYSTROPHY/ MD………………………………………………………………………………….469

MUSCLE RELAXANT…………………………………………………………………………………………………469

NABILONE…………………………………………………………………………………………………………………470

NAIL-PATELLA SYNDROME………………………………………………………………..475

NAUSEA…………………………………………………………………………………………………………………….475

NEURONS/ BRAIN CELLS………………………………………………………………………………………….481

NEUROPATHIC PAIN…………………………………………………………………………………………………487

NEUROPROTECTANT………………………………………………………………………………………………..492

NIEMANN-PICK DISEASE………………………………………………………………………………………….497

NIGHT SWEATS……………………………………………………………………………….498

NUTRITION – GENERAL…………………………………………………………………………………………….498

NUTRITION – HEMP SEED…………………………………………………………………………………………499

NUTRITION – HEMP SEED OIL…………………………………………………………………………………..502

O-1602………………………………………………………………………………………….504

O-1966………………………………………………………………………………………….504

OBESITY…………………………………………………………………………………………………………………….505

OBSESSIVE COMPULSIVE DISORDER………………………………………………………………………510

OMEGA-3/ CB1 CONNECTION ………………………………………………………………511

679ORGAN TRANSPLANTS………………………………………………………………………………………512

OSTEOPOROSIS/ BONES…………………………………………………………………………………………..514

OVERDOSES……………………………………………………………………………………………………………..517

OVERVIEWS……………………………………………………………………………………………………………..517

PAIN…………………………………………………………………………………………………………………………..519

PANCREATITIS………………………………………………………………………………………………………….527

PERINATAL HYPOXIC-ISCHEMIC INJURY……………………………………………….528

PARKINSON’S DISEASE…………………………………………………………………………………………….529

PATENTS RELATED TO CANNABIS………………………………………………………………………….532

PEA – PALMITOYLETHANOLAMIDE………………………………………………………537

PHARC…………………………………………………………………………………………538

PHYTOCANNABINOIDS / PLANT EXTRACTS…………………………………………………………..539

POISONING – ORGANOPHOSPHATE……………………………………………………….544

POISONING – PARAQUAT…………………………………………………………………..544

POST-OPERATIVE PAIN…………………………………………………………………………………………….545

POST TRAUMATIC STRESS DISORDER/ PTSD………………………………………………………….546

PRADER WILLI SYNDROME………………………………………………………………..549

PREGNANCY/ PRENATAL EXPOSURE……………………………………………………………………..550

PRIONS………………………………………………………………………………………………………………………555

PROXIMAL MYOTONIC MYOPATHY / PROMM……………………………………………………….556

PRURITIS (chronic itch)…………………………………………………………………………………………..556

PSORIASIS…………………………………………………………………………………………………………………558

QUITTING CANNABIS……………………………………………………………………….559

QUITTING OTHER DRUGS…………………………………………………………………………………………560

RADIATION-INDUCED NAUSEA……………………………………………………………………………….563

RADIATION SICKNESS………………………………………………………………………564

REFLEX SYMPATHETIC DYSTROPHY……………………………………………………564

RESTLESS LEG SYNDROME……………………………………………………………………………………..564

RETINITIS PIGMENTOSA……………………………………………………………………565

RIMONABANT…………………………………………………………………………………………………………..565

R(+)-METHANANANDAMIDE…………………………………………………………………………………569

RWJ- 400065……………………………………………………………………………………………………………… 571

SAFETY AS A MEDICINE…………………………………………………………………………………………..571

SAFETY-ADULTERANTS/ CONTAMINANTS…………………………………………………………….573

680SATIVEX………………………………………………………………………………………………………………575

SCHIZOPHRENIA/ MENTAL DISORDERS…………………………………………………………………578

SCLERODERMA………………………………………………………………………………………………………..585

SEPTIC SHOCK………………………………………………………………………………………………………….586

SICKLE CELL DISEASE……………………………………………………………………………………………..587

SINUSITIS……………………………………………………………………………………………………….. ………587

SLEEPING SICKNESS/ TRYPANOSOMIASIS………………………………………………588

SLEEP MODULATION………………………………………………………………………………………………..588

SMALLPOX…………………………………………………………………………………….590

SMELL / ODOR DETECTION…………………………………………………………………590

SMOKED CANNABIS AS A MEDICATION…………………………………………………………………591

SOCIAL ADJUSTMENT/ BEHAVIOR………………………………………………………………………….595

SPASTICITY……………………………………………………………………………………………………. ………597

SPICE……………………………………………………………………………………………601

SPINAL CORD INJURY………………………………………………………………………………………………603

SPLEEN…………………………………………………………………………………………606

STEM CELLS…………………………………………………………………………………..606

STRESS…………………………………………………………………………………………607

STORAGE………………………………………………………………………………………608

STROKE……………………………………………………………………………………………………………………..608

TAK SERIES…………………………………………………………………………………..612

TASTE………………………………………………………………………………………….612

TAXONOMY/ GENETICS OF CANNABIS…………………………………………………………………..613

TEA AS MEDICINE…………………………………………………………………………………………………….617

TEETH /DENTISTRY…………………………………………………………………………………………………..617

THC/ TETRAHYDROCANNABINOL…………………………………………………………………………..618

THC ACID/ THCA……………………………………………………………………………………………………….636

TETRAHYDROCANNABINOL-HEMISUCCINATE / THC-HS……………………………………..637

TETRAHYDROCANNABOVARIN/ THCV…………………………………………………………………..638

TIME PERCEPTION……………………………………………………………………………640

TINNITUS- also see HEARING ………………………………………………………………………………..640

TOBACCO VS CANNABIS………………………………………………………………………………………….641

TOLERANCE………………………………………………………………………………………………………………645

TOURETTE’S SYNDROME…………………………………………………………………………………………646

TRICHOTILLOMANIA………………………………………………………………………..648

TUBERCULOSIS…………………………………………………………………………………………………………648

ULCERATIVE COLITIS – see COLITIS, also BOWEL DISORDERS

URB – 597/ KDS-4103…………………………………………………………………………………………………649

URB – 754…………………………………………………………………………………………………………………..651

URB – 973…………………………………………………………………………………………………………………..651

681VAPORIZERS – see METHODS OF USE- VAPORIZERS

VETERINARY USE/ ANIMALS…………………………………………………………………………………..652

VISION……………………………………………………………………………………………………………………….654

WILSON’S DISEASE………………………………………………………………………………………………….657

WIN 55,212-2………………………………………………………………………………………………………………657

WITHDRAWAL SYNDROME……………………………………………………………………………………..669

WOUNDS/ INJURIES…………………………………………………………………………………………………..670

YOUNG ADULTS – see CHILDREN/YOUNG ADULTS